Avera Oneill Family Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 403 E Hynes Ave, Oneill, NE 68763 Phone: 402-336-2622 Fax: 402-336-3240 |
Midtown Health Center, Inc. Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 422 E Douglas St, Oneill, NE 68763 Phone: 402-371-8000 Fax: 402-371-0971 |
Avera Medical Group O'neill Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 N 2nd St, Oneill, NE 68763 Phone: 402-336-2611 Fax: 402-336-5137 |
Elkhorn Valley Family Medicine, Pc Clinic/Center Medicare: Medicare Enrolled Practice Location: 304 E Douglas St, Oneill, NE 68763 Phone: 402-336-4222 Fax: 402-336-4228 |
Finish Line Chiropractic & Acupuncture Clinic/Center Medicare: Medicare Enrolled Practice Location: 403 E Hynes Ave, Oneill, NE 68763 Phone: 402-336-9979 |
Avera Holt County Medical Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 555 E John St, Oneill, NE 68763 Phone: 402-336-4113 |
Avera Medical Group O'neill Family Medicine Medicare: Medicare Enrolled Practice Location: 300 N 2nd St, Suite 100, Oneill, NE 68763 Phone: 402-336-2900 |
News Archive
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced positive results from the Phase 1 portion of its Phase 1/1b study of defactinib (VS-6063) in combination with paclitaxel in patients with ovarian cancer that were presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
A new device that uses near-infrared light to non-invasively monitor the oxygenation of the brain during surgery appears to be a promising alternative to the more invasive techniques currently in use, according to a new study by Duke University Medical Center anesthesiologists.
The Pulmonary Fibrosis Foundation and Veracyte, Inc. announced that the organizations are partnering on a U.S. patient survey to advance understanding of patients' diagnostic experiences with interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF).
Many of the vaccines critically needed to fight some of the world's most prevalent infectious diseases are not likely to be developed, a new analysis of current candidates in the research and development pipeline has found.
The Results for Development Institute has launched a new website on universal health coverage, UHC Forward, "that features news, events, and publications related to the global UHC movement," an institute press release states.
› Verified 2 days ago